Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Global Tech ETF (IXN) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

iShares Global Tech ETFTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares Global Tech ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? iShares Global Tech ETF trades at $148.87 (market cap $10.08B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: iShares Global Tech ETF is far larger — about 4.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and iShares Global Tech ETF is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.

IXNSLS
Market Cap
$10.08B$2.28B
Volume
134,4633,128,960
Sector
Sector/ThematicHealth
52-Week High
$152.94$15.46
52-Week Low
$95.76$1.39
Typical Hold Time
46 Days—
Enterprise Value
—$2.15B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Global Tech ETF

IXN trades at $152.16, down 0.51% today but near its 52-week high of $151.40, reflecting strong momentum. Technical indicators show a bullish moving average signal but overbought RSI levels. Recent news highlights the ETF's 34% gain and multiple compression, with a high-teens P/E ratio and 28.5% long-term EPS growth rate, emphasizing global tech exposure beyond the U.S.

The outlook remains positive due to AI exposure and global diversification, but risks include portfolio concentration and overbought conditions. Analyst sentiment is bullish, with buy ratings citing valuation appeal, though investors should monitor tech sector volatility and competitive pressures from international firms.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IXN
37% Buy63% Sell
Avg holding period · 46 Days
SLS

No sentiment data available yet.

About iShares Global Tech ETF

IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.

Read more on IXN →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →